Latest Breaking News On - Accelerating reversal - Page 1 : comparemela.com

Ocuphire Announces Positive Topline Results from MIRA-3 Phase 3 FDA Registration Trial for Nyxol® in the Reversal of Mydriasis - read this article along with other careers information, tips and advice on BioSpace

Corey davisOcuphire pharmaIuvo bioscienceMina soochNyxol development planOculos development servicesOcuphire pharma incMeets primary endpoint withSubjects returningBaseline pupil diameterPlacebo subjectsTrial showing substantial benefitAccelerating reversalOnly dilation reversal dropWebcast todayDevelopment plan